Mentioned On
Episode Mentions
Squawk Pod · Jan 9, 2026
5 Things to Know Before the Opening Bell 1/9/26
“Reportedly in talks to acquire cancer drug maker RevMed for between $28-32 billion according to Financial Times”
Pharmaceutical M&A and Industry ConsolidationCancer Drug Development and AcquisitionFitness Tracking Technology IPOs
View Analysis